[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346037-105":59,"doc-detail-346037-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","prognostic-significance-of-nlrp-3-expression-in-solid-cancers-a-systematic-review-and-meta-analysis","Prognostic significance of NLRP-3 expression in solid cancers - a systematic review and meta-analysis","","Background: The inflammasome is a critical immunological sensor comprised of NLRP-3, ASC, and CASPASE-1, and while NLRP-3 mutations are common in inflammatory disease, its role in cancer remains controversial. Methods: PubMed, Embase, Cochrane, and Google Scholar were searched for NLRP-3 expression and cancer outcome data, pooled with RevMan hazard ratios and Mantel–Haenszel odds ratios, with TCGA PANCAN RNA-seq datasets for external validation. Results: Higher NLRP-3 expression associates with larger tumors, advanced grade, higher TNM stage, metastasis, and worse OS and DFS. Conclusion: High NLRP-3 expression links to advanced disease and poor outcomes across many solid tumors.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prognostic-significance-of-nlrp-3-expression-in-solid-cancers-a-systematic-review-and-meta-analysis/346037/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prognostic-significance-of-nlrp-3-expression-in-solid-cancers-a-systematic-review-and-meta-analysis/346037.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main question of this systematic review and meta-analysis?","Question",{"text":113,"@type":114},"Whether NLRP-3 expression is associated with clinical outcomes in patients with solid cancers.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were studies identified and pooled?",{"text":118,"@type":114},"PubMed, Embase, Cochrane, and Google Scholar were searched for NLRP-3 expression and disease outcome data; pooled hazard ratios were calculated in RevMan, and Mantel–Haenszel pooled odds ratios were used. TCGA PANCAN datasets supported external validation.",{"name":120,"@type":111,"acceptedAnswer":121},"What outcomes are linked to higher NLRP-3 expression?",{"text":122,"@type":114},"Higher NLRP-3 expression correlates with poorer overall survival (OS) and disease-free survival (DFS), and with advanced tumor characteristics including size, grade, TNM stage, and metastasis.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},346037,1790841745,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","AnnAls of Medicine  \n2026, Vol. 58, no. 1, 2712701  \n[https://doi.org/10.1080/07853890.2026.2712701](https://doi.org/10.1080/07853890.2026.2712701)  \nRESEARCH ARTICLE     \nPrognostic significance of NLRP-3 expression in solid cancers: a systematic review and meta-analysis  \nNishant Thakura,b,c, Muhammad Alamgeera,d,e, Manu Kumarf, Quinton Luonga,b,  \nJamshid Abdul-Ghafarg, Surein Arulanandaa,d,e, Ashley Mansellh and Daniel J. Gougha,b   \nacentre for cancer Research, Hudson institute of Medical Research, clayton, Vic, Australia; bdepartment of Molecular and Translational science, Monash University, clayton, Vic, Australia; cPeninsula and south-east oncology, frankston, Vic, Australia; ddepartment of Medical oncology, Monash Health, clayton, Australia; eschool of clinical sciences, faculty of Medicine, nursing and Health sciences, Monash University, clayton, Australia; fdepartment of Animal, Plant and soil sciences, la Trobe University, AgriBio, Bundoora, Vic, Australia; gdepartment of Pathology, Molecular and cell-Based Medicine, icahn school of Medicine at Mount sinai, new York, nY, UsA; hdepartment of Microbiology, Anatomy, Physiology and Pharmacology, la Trobe University, Bundoora, Vic, Australia  \nABSTRACT  \nBackground: The inflammasome is a critical immunological sensor comprised of NLRP-3, ASC, and CASPASE-1. Mutations in NLRP-3 are prevalent in inflammatory diseases. However, the role of NLRP-3 in cancer is controversial. This study investigates whether NLRP-3 expression is associated with clinical outcomes in patients with solid cancers.  \nMethods: PubMed (MEDLINE), Embase, Cochrane, and Google Scholar were searched for articles reporting NLRP-3 expression and disease outcome data in cancer patients. RevMan Review Manager was used to calculate pooled hazard ratios and Mantel– Haenszel pooled odds ratios. RNA sequencing datasets from the TCGA Pan-Cancer (PANCAN) were used for external validation.  \nResults: Patients with higher NLRP-3 expression showed a significant association with larger tumor size, advanced tumor grade, TNM stage, and presence of metastasis. High NLRP-3 expression has a significant association with poor OS (HR:2.12, 95% CI = 1.49– 3.03), p \u003C 0.0001) and DFS (HR:1.86, 95% CI = 1.30– 2.65, p = 0.0007). Subgroup analysis showed that higher NLRP-3 expression is associated with worse OS in head and neck cancer (HR: 2.77, 95% CI = 1.88–4.09, p \u003C 0.00001), colorectal cancers (HR:2.14, 95% CI= 1.59– 2.87, p \u003C 0.00001), and pancreatic cancer patients (HR: 3.19, 95% CI = 1.73–5.91, p = 0.0002).  \nConclusion: High NLRP-3 expression is associated with advanced disease and poor outcomes in many solid tumours.  \nIntroduction  \nARTICLE HISTORY  \nReceived 9 October 2025 Accepted 27 July 2026  \nKEYWORDS  \nNLRP-3; epithelial– mesenchymal transition; cancer stem cells; tumour microenvironment; prognosis; overall survival; and disease-free survival  \nChronic inflammation predisposes individuals to cancer development and can be attributed to 15–20% of all cancer cases [1] . Interleukin-1β (IL-1β) is a prototypic pro-inflammatory cytokine, primarily secreted by immune cells in response to inflammatory insults and is associated with poor survival in cancer patients [2,3] . The link between IL-1β and cancer was thrust into the spotlight following the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) clinical trial of a neutralizing IL-1β antibody for atherosclerotic patients. Retrospective analysis showed that IL-1β neutralization significantly reduced the onset of lung cancer when used in the prophylactic setting [4] . IL-1β is produced in an inactive pro-form that is cleaved into its biologically active form. The Inflammasome is a primary source of biologically active IL-1β [5,6] . Inflammasomes are protein complexes typically comprised of a NOD-Like receptor  \nCONTACT d. J. Gough  [daniel.gough@hudson.org.au](daniel.gough@hudson.org.au)  The Hudson institute of Medical Research, 27– 31 Wright st, clayton, V","cbCaiozjKJmIcjIc","https://ap.wps.com/l/cbCaiozjKJmIcjIc","pdf",1900256,"English","# Abstract\n# Introduction\n# Methods\n# Results\n## Associations with clinicopathological variables\n## Subgroup findings\n# Conclusion","[{\"question\":\"What is the main question of this systematic review and meta-analysis?\",\"answer\":\"Whether NLRP-3 expression is associated with clinical outcomes in patients with solid cancers.\"},{\"question\":\"How were studies identified and pooled?\",\"answer\":\"PubMed, Embase, Cochrane, and Google Scholar were searched for NLRP-3 expression and disease outcome data; pooled hazard ratios were calculated in RevMan, and Mantel–Haenszel pooled odds ratios were used. TCGA PANCAN datasets supported external validation.\"},{\"question\":\"What outcomes are linked to higher NLRP-3 expression?\",\"answer\":\"Higher NLRP-3 expression correlates with poorer overall survival (OS) and disease-free survival (DFS), and with advanced tumor characteristics including size, grade, TNM stage, and metastasis.\"}]","Prognostic significance of NLRP-3 expression in solid cancers - a systematic review and meta-analysis | PDF",1790059792,48,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/56216d897895f184204daa1ea666f7fe.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9480864e058838909bd5133ecb88580c.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d8ddb0f2e4a5bbe47903e6bb64d80272.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/af678cedfd60ba8bf9a4c536e03537da.webp",980,1306]